DTIL
Precision BioSciences Inc
NASDAQ: DTIL · HEALTHCARE · BIOTECHNOLOGY
$7.15
+3.62% today
Updated 2026-04-30
Market cap
$181.66M
P/E ratio
—
P/S ratio
5.30x
EPS (TTM)
$-3.63
Dividend yield
—
52W range
$4 – $9
Volume
0.3M
WallStSmart proprietary scores
45
out of 100
Grade: C
Sell
Investment rating
7.3
Growth
B+5.0
Quality
C+4.0
Profitability
C6.7
Valuation
B—/9
Piotroski F-Score
—
—
Altman Z-Score
—
—
Industry rank
—
View all highly rated stocks (75+) →206 stocks currently score above 75
Price targets
Analyst target
$32.00
+347.55%
12-Month target
—
—
Intrinsic (DCF)
$13.18
Margin of safety
+69.12%
0 Strong Buy4 Buy0 Hold0 Sell0 Strong Sell
Price chart
X-Ray snapshot
Strengths
+ Revenue growth 5,261.00% QoQ
+ 69.12% below intrinsic value
Risks
- Thin margins at -133.50%
- Negative free cash flow $-11.28M
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $25.10M | $48.73M | $68.70M | $34.26M | $34.26M |
| Net income | $-111.64M | $-61.32M | $7.17M | $-46.61M | $19.25M |
| EPS | — | — | — | — | $-3.63 |
| Free cash flow | $-49.07M | $-86.39M | $-58.70M | $-65.93M | $-11.28M |
| Profit margin | -444.80% | -125.84% | 10.43% | -136.03% | -133.50% |
Peer comparison
Smart narrative
Precision BioSciences Inc trades at $7.15. Our Smart Value Score of 45/100 indicates the stock is fair. TTM revenue stands at $34.26M. with profit margins at -133.50%. Our DCF model estimates intrinsic value at $13.18.
Frequently asked questions
What is Precision BioSciences Inc's stock price?
Precision BioSciences Inc (DTIL) trades at $7.15.
Is Precision BioSciences Inc overvalued?
Smart Value Score 45/100 (Grade C, Sell). DCF value $13.18.
What is the price target of Precision BioSciences Inc (DTIL)?
The analyst target price is $32.00, representing +347.6% upside from the current price of $7.15.
What is the intrinsic value of Precision BioSciences Inc (DTIL)?
Based on our DCF model, intrinsic value is $13.18, a +69.1% margin of safety versus $7.15.
What is Precision BioSciences Inc's revenue?
TTM revenue is $34.26M.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio5.30x
ROE-62.70%
Beta1.09
50D MA$5.74
200D MA$5.21
Shares out0.03B
Float0.02B
Short ratio—
Avg volume0.3M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—